You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 66 No. 12, December 2009 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Original Article
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neurology
 •Neurotoxicology
 •Occupational and Environmental Medicine
 •Psychiatry
 •Anxiety Disorders
 •Depression
 •Panic Disorder
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Blood Lead Levels and Major Depressive Disorder, Panic Disorder, and Generalized Anxiety Disorder in US Young Adults

Maryse F. Bouchard, PhD, MSc; David C. Bellinger, PhD, MSc; Jennifer Weuve, MPH, ScD; Julia Matthews-Bellinger, PhD, MD; Stephen E. Gilman, ScD; Robert O. Wright, MD, MPH; Joel Schwartz, PhD; Marc G. Weisskopf, PhD

Arch Gen Psychiatry. 2009;66(12):1313-1319.

Context  Lead is a ubiquitous neurotoxicant, and adverse cognitive and behavioral effects are well-documented in children and occupationally exposed adults but not in adults with low environmental exposure.

Objective  To investigate the association of current blood lead levels with 3 common psychiatric disorders—major depression, panic, and generalized anxiety—in young adults.

Design  Cross-sectional epidemiologic survey.

Setting  Nationally representative sample of US adults.

Participants  A total of 1987 adults aged 20 to 39 years who responded to the National Health and Nutrition Examination Survey (1999-2004).

Main Outcome Measures  Twelve-month DSM-IV criteria–based diagnoses of major depressive disorder, panic disorder, and generalized anxiety disorder assessed using the Composite International Diagnostic Interview.

Results  The mean (SD) blood lead level was 1.61 (1.72) µg/dL (range, 0.3-37.3 µg/dL) (to convert to micromoles per liter, multiply by 0.0483). Increasing blood lead levels were associated with higher odds of major depression (P = .05 for trend) and panic disorder (P = .02 for trend) but not generalized anxiety disorder (P = .78 for trend) after adjustment for sex, age, race/ethnicity, education status, and poverty to income ratio. Persons with blood lead levels in the highest quintile had 2.3 times the odds of major depressive disorder (95% confidence interval [CI], 1.13-4.75) and 4.9 times the odds of panic disorder (1.32-18.48) as those in the lowest quintile. Cigarette smoking was associated with higher blood lead levels and outcome, but models that excluded current smokers also resulted in significantly increased odds of major depression (P = .03 for trend) and panic disorder (P = .01 for trend) with higher blood lead quintiles.

Conclusions  In these young adults with low levels of lead exposure, higher blood lead levels were associated with increased odds of major depression and panic disorders. Exposure to lead at levels generally considered safe could result in adverse mental health outcomes.


Author Affiliations: Département de santé environementale et santé au travail, Université de Montréal, Montréal, Québec, Canada (Dr Bouchard); Departments of Neurology and Environmental Health, Harvard Medical School, Harvard School of Public Health, Children's Hospital, Boston, Massachusetts (Dr Bellinger); Rush Institute for Healthy Aging, Rush University Medical Center, Chicago, Illinois (Dr Weuve); Departments of Environmental Health (Drs Bouchard, Weuve, Wright, Schwartz, and Weisskopf), Society, Human Development, and Health (Dr Gilman), and Epidemiology (Drs Gilman, Schwartz, and Weisskopf), Harvard School of Public Health; Department of Psychiatry, University of Massachusetts Medical School, Worcester (Dr Matthews-Bellinger); Department of Pediatrics, Harvard Medical School, Children's Hospital (Dr Wright); and Channing Laboratory, Department of Medicine, Harvard Medical School and Brigham and Women's Hospital, Boston (Dr Weisskopf).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

This Month in Archives of General Psychiatry
Arch Gen Psychiatry. 2009;66(12):1285.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Childhood and Adult Socioeconomic Position, Cumulative Lead Levels, and Pessimism in Later Life: The VA Normative Aging Study
Peters et al.
Am J Epidemiol 2011;174:1345-1353.
ABSTRACT | FULL TEXT  

Rebooting Psychotherapy Research and Practice to Reduce the Burden of Mental Illness
Kazdin and Blase
Perspectives on Psychological Science 2011;6:21-37.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.